InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,725.31
(
1.44%
)

Replies to post #3843 on GTC Biotherapeutics (fka GTCB)

Replies to #3843 on GTC Biotherapeutics (fka GTCB)
icon url

DewDiligence

06/16/07 1:13 AM

#3844 RE: ThomasS #3843

The “exploratory, dose ranging study” is the phase-2 RA study whose extension (testing a higher dose) is still in progress. The immediately following sentence in the PR clarifies the context.